Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/16 → 9/27/20 |
Funding
- INC Research, LLC (Prot #GX29176 // Prot #GX29176)
- Genentech, Inc (Prot #GX29176 // Prot #GX29176)
Prot #GX29176: A Phase III, Multicenter, Randomized, Double-masked, Sham-controlled Study to Assess the Efficacy and Safety of Lampalizumab Administered Intravitreally to Patients with Geographic Atrophy Secondary to Age Related Macular Degeneration
- Gill, Manjot K (PD/PI)
Project: Research project